Briacell Therapeutics Net Income Over Time
| BCT Stock | 6.74 8.48 55.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Briacell Therapeutics Performance and Briacell Therapeutics Correlation. Briacell |
Cross Equities Net Income Analysis
Compare Briacell Therapeutics and related stocks such as Resverlogix Corp, Perimeter Medical Imaging, and Hemostemix Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVX | (39.2 K) | (18.8 M) | 43.4 M | (55.1 M) | 18.3 M | (19.7 M) | (46.2 M) | (58.3 M) | (162.8 K) | 118 M | 2.5 K | (24.8 M) | (3.6 M) | (16.7 M) | (7.6 M) | (8.8 M) | (9.2 M) |
| PINK | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (10.5 M) | (8 M) | (16.8 M) | (3.6 M) | (18.9 M) | (13.4 M) | (12.1 M) | (12.7 M) |
| HEM | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (4.3 M) | (4 M) | (3.8 M) | (3.9 M) | (6.2 M) | (4.9 M) | (7.8 M) | (6.3 M) | (5.2 M) | (2.5 M) | (2.6 M) | (2.4 M) | (2.5 M) |
| MBX | (100 K) | (2.6 M) | 1.4 K | 169 K | 614 K | 748.4 K | (3.8 M) | (8.6 M) | 31.9 K | (6.2 M) | 1.6 M | 1.8 M | (39.5 K) | 3.5 M | (2.2 M) | (2.6 M) | (2.7 M) |
Briacell Therapeutics and related stocks such as Resverlogix Corp, Perimeter Medical Imaging, and Hemostemix Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Briacell Therapeutics financial statement analysis. It represents the amount of money remaining after all of Briacell Therapeutics Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Briacell Therapeutics Corp | BCT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Bellevue Centre, West |
| Exchange | Toronto Exchange |
null 6.74
Check out Briacell Therapeutics Performance and Briacell Therapeutics Correlation. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Briacell Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.